Transforming the Future of Cell Therapies
In CellRep, we develop cell reprogramming strategies to increase the functionality of immune cells,
aiming at improving the efficacy of cell therapies.
End-to-end pipeline from target discovery to preclinical validation of cell reprogramming strategies.
Our Technology and Platform
We have developed an innovative approach to enhance T cell functionality by reprogramming these cells to a rejuvenated state and with improved therapeutic potential.
Our platform includes:
Target and Drug Discovery
Bioinformatics and AI-driven discovery of druggable targets
In vitro Screening
Optimized drug screening platform to analyze biomarkers at the single-cell level.
Preclinical testing
Cutting-edge in vivo models for PoC studies
By integrating these cell reprogramming strategies into the cell therapy manufacturing workflow, more powerful and effective therapies against cancer and other chronic conditions will be delivered to patients in need.